NO20015598D0 - Nye krystallinske former av makrolidantibiotika - Google Patents

Nye krystallinske former av makrolidantibiotika

Info

Publication number
NO20015598D0
NO20015598D0 NO20015598A NO20015598A NO20015598D0 NO 20015598 D0 NO20015598 D0 NO 20015598D0 NO 20015598 A NO20015598 A NO 20015598A NO 20015598 A NO20015598 A NO 20015598A NO 20015598 D0 NO20015598 D0 NO 20015598D0
Authority
NO
Norway
Prior art keywords
crystalline forms
macrolide antibiotics
new crystalline
macrolide
antibiotics
Prior art date
Application number
NO20015598A
Other languages
English (en)
Other versions
NO320195B1 (no
NO20015598L (no
Inventor
Robert John Rafka
Douglas John Meldrum Allen
Colman Brendan Ragan
Barry James Morton
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20015598D0 publication Critical patent/NO20015598D0/no
Publication of NO20015598L publication Critical patent/NO20015598L/no
Publication of NO320195B1 publication Critical patent/NO320195B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20015598A 1999-05-18 2001-11-16 Nye krystallinske former av en makrolidantibiotika-forbindelse, farmasoytisk blanding omfattende forbindelsen, fremgangsmate for fremstilling derav, samt anvendelse derav. NO320195B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13464499P 1999-05-18 1999-05-18
PCT/IB2000/000463 WO2000069874A1 (en) 1999-05-18 2000-04-14 Novel crystalline forms of a macrolide antibiotic

Publications (3)

Publication Number Publication Date
NO20015598D0 true NO20015598D0 (no) 2001-11-16
NO20015598L NO20015598L (no) 2002-01-08
NO320195B1 NO320195B1 (no) 2005-11-14

Family

ID=22464300

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015598A NO320195B1 (no) 1999-05-18 2001-11-16 Nye krystallinske former av en makrolidantibiotika-forbindelse, farmasoytisk blanding omfattende forbindelsen, fremgangsmate for fremstilling derav, samt anvendelse derav.

Country Status (43)

Country Link
US (1) US6583274B1 (no)
EP (1) EP1189912B1 (no)
JP (1) JP3897983B2 (no)
KR (1) KR100474229B1 (no)
CN (1) CN1203084C (no)
AP (1) AP2001002325A0 (no)
AR (1) AR020030A1 (no)
AT (1) ATE392427T1 (no)
AU (1) AU772283B2 (no)
BG (1) BG106150A (no)
BR (1) BR0011300A (no)
CA (1) CA2372206C (no)
CZ (1) CZ20014120A3 (no)
DE (1) DE60038610T2 (no)
DK (1) DK1189912T3 (no)
DZ (1) DZ3043A1 (no)
EA (1) EA003417B1 (no)
ES (1) ES2302689T3 (no)
GT (1) GT200000072A (no)
HK (1) HK1045521B (no)
HN (1) HN2000000056A (no)
HR (1) HRP20010849A2 (no)
HU (1) HUP0201341A3 (no)
IL (2) IL145946A0 (no)
IS (1) IS6127A (no)
MA (1) MA26735A1 (no)
MX (1) MXPA01011914A (no)
MY (1) MY133397A (no)
NO (1) NO320195B1 (no)
NZ (1) NZ514765A (no)
OA (1) OA11876A (no)
PA (1) PA8495001A1 (no)
PE (1) PE20010151A1 (no)
PL (1) PL353316A1 (no)
PT (1) PT1189912E (no)
SK (1) SK16472001A3 (no)
TN (1) TNSN00103A1 (no)
TW (1) TWI225066B (no)
UA (1) UA67842C2 (no)
UY (1) UY26144A1 (no)
WO (1) WO2000069874A1 (no)
YU (1) YU76601A (no)
ZA (1) ZA200109420B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
MXPA02007305A (es) 2000-01-27 2002-11-29 Pfizer Prod Inc Composiciones antiboticas de azalida.
JP4104463B2 (ja) * 2001-04-27 2008-06-18 ファイザー・プロダクツ・インク ４’’−置換された−９−デオキソ−９ａ−アザ−９ａ−ホモエリスロマイシン誘導体を製造するための方法
EP1435359A1 (en) * 2002-12-31 2004-07-07 Alembic Limited A process for the purification of roxithromycin
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
MA32997B1 (fr) * 2009-01-30 2012-01-02 Glaxo Group Ltd Macrolide anti-inflammatoire
EP2402355A1 (en) * 2010-07-01 2012-01-04 Novartis AG Crystalline anhydrous forms II and III of Tulathromycin
WO2013013834A1 (en) 2011-07-27 2013-01-31 Farma Grs, D.O.O. New crystalline forms of tulathromycin
CN106008622A (zh) * 2016-08-02 2016-10-12 海门慧聚药业有限公司 泰拉霉素新晶型及其制备
CN109942652B (zh) * 2017-12-21 2022-04-26 洛阳惠中兽药有限公司 一种莱柯霉素晶型ⅰ及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO107257B1 (ro) * 1987-07-09 1993-10-30 Pfizer Procedeu de obtinere a unui dihidrat de azitromicina, cristalin
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
US5844105A (en) * 1996-07-29 1998-12-01 Abbott Laboratories Preparation of crystal form II of clarithromycin
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.

Also Published As

Publication number Publication date
HRP20010849A2 (en) 2003-04-30
IL145946A (en) 2007-06-17
KR100474229B1 (ko) 2005-03-08
KR20020007415A (ko) 2002-01-26
CN1351607A (zh) 2002-05-29
AP2001002325A0 (en) 2001-12-31
HK1045521A1 (en) 2002-11-29
IL145946A0 (en) 2002-07-25
TNSN00103A1 (fr) 2005-11-10
GT200000072A (es) 2001-11-08
SK16472001A3 (sk) 2003-02-04
HK1045521B (zh) 2005-12-09
ES2302689T3 (es) 2008-08-01
HN2000000056A (es) 2001-02-02
EP1189912A1 (en) 2002-03-27
TWI225066B (en) 2004-12-11
MXPA01011914A (es) 2002-05-06
CA2372206A1 (en) 2000-11-23
HUP0201341A3 (en) 2003-03-28
EP1189912B1 (en) 2008-04-16
CA2372206C (en) 2006-01-10
CZ20014120A3 (cs) 2003-01-15
NO320195B1 (no) 2005-11-14
UA67842C2 (uk) 2004-07-15
EA003417B1 (ru) 2003-04-24
DE60038610T2 (de) 2009-06-25
YU76601A (sh) 2004-09-03
DE60038610D1 (de) 2008-05-29
JP2002544283A (ja) 2002-12-24
NO20015598L (no) 2002-01-08
CN1203084C (zh) 2005-05-25
BR0011300A (pt) 2002-02-26
US6583274B1 (en) 2003-06-24
DZ3043A1 (fr) 2004-03-27
MY133397A (en) 2007-11-30
EA200100984A1 (ru) 2002-06-27
UY26144A1 (es) 2000-12-29
OA11876A (en) 2006-03-27
IS6127A (is) 2001-10-26
DK1189912T3 (da) 2008-06-30
BG106150A (bg) 2002-05-31
AU3572900A (en) 2000-12-05
ZA200109420B (en) 2002-11-15
PA8495001A1 (es) 2002-02-21
AU772283B2 (en) 2004-04-22
AR020030A1 (es) 2002-03-27
HUP0201341A2 (en) 2002-08-28
WO2000069874A1 (en) 2000-11-23
ATE392427T1 (de) 2008-05-15
PT1189912E (pt) 2008-05-16
PL353316A1 (en) 2003-11-17
NZ514765A (en) 2004-05-28
JP3897983B2 (ja) 2007-03-28
PE20010151A1 (es) 2001-02-08
MA26735A1 (fr) 2004-12-20

Similar Documents

Publication Publication Date Title
NO20012155D0 (no) Nye makrolid-antibiotika
ID30233A (id) Antibiotika ketolida
DE60124594D1 (de) Makrolidantibiotika
NO20003347D0 (no) Nye macrolider
NO20010619D0 (no) Krystallin base av citalopram
EE200300575A (et) Asitromütsiini kristalsed vormid
NO20020814D0 (no) Nye spiroforbindelser
NO20015664D0 (no) Nye farmasöytisk aktive forbindelser
NO20010916D0 (no) Nye antibakterielle isoksazolinoner
NO20020810D0 (no) Nye fenylpiperaziner
DK1237857T3 (da) Nye Phenalkyloxyphenylderivater
NO20015598D0 (no) Nye krystallinske former av makrolidantibiotika
NO20016389D0 (no) Fremgangsmåte for fremstilling av substituerte cyklopentanderivater og nye krystallinske strukturer derav
NO20024527L (no) Krystallinsk form II av kabergolin
NO20013857D0 (no) Krystallinsk form av Eplerenon
ID26418A (id) METODA KRISTALISASI ANTIBIOTIK β-LAKTAM
NO20010553D0 (no) Krystallinske former av osanetant
NO994027D0 (no) Polymorf av zopolrestat-monohydrat
AU2003285599A1 (en) Novel semisynthetic macrolide antibiotics of the azalide series
NO20016200L (no) Antibiotika
NO20004364L (no) Nye saltformer av (2E)-5-amino-5-metylheks-2-ensyre-N-metyl-N-
SE9904417D0 (sv) Crystalline form